New Guidelines Issued for ADHD Management in Children

The Haute Autorité de santé releases recommendations to improve diagnosis and treatment of ADHD, addressing long-standing controversies.

• ADHD affects approximately 5 to 5.5% of children globally, yet treatment access remains limited in France.
• Only 15 to 20% of children in France who need ADHD medication, such as Ritalin, receive it, partly due to a shortage of qualified prescribers.
• The new guidelines aim to clarify diagnostic procedures and treatment options, providing a 'mode d'emploi' for families and healthcare providers.
• Misconceptions about ADHD contribute to stigma and can delay effective treatment, as highlighted by international experts.
• The recommendations are a significant step toward recognizing ADHD as a legitimate neurodevelopmental disorder, offering hope to affected families.

3 Articles

Sud Ouest Le Parisien Le Parisien